Choose Your Location

Select Country

United Kingdom

Your cart
Close Icon Created with Sketch.
No items found

Your PCR booking reference starts with “RIGHT” and you will receive it once you place your order.

Changing the status quo

We built an online platform through which we wanted to see a change in the way healthcare was delivered to our close family members. Now we want to change the status quo.

We believe that the future of healthcare lies in precision medicine coupled with advanced digital tools.  Our goal is to enable the use of medical technologies in everyday life so that we can improve the health and wellness of our users.

Our DNA

Physical characteristics, attribute and medical conditions are nothing but the result of a complex interaction between our genes and environmental factors. To make a sensible insight and an informed action plan, we must first decode these causative factors.

We believe that:
Genotype + Environment = Phenotype.

To decode this simple equation, we:

A.    Engage a qualified partner specialist whenever a clinical report is set to be sent out to one of our patients, in order to provide an accurate and actionable interpretation.

B.    Maintain the highest level of quality and privacy in our service.

C.    Communicate information in an understandable and UI friendly manner to the general public, whilst presenting information that is appropriate for further medical advice.

The Story so Far..

The Need

It all started with a drug complication that Rightangled’s co-founder saw first hand in her family. Floriane's relative was experiencing drug side effects and responding poorly to an anticoagulant drug. The medication was Plavix (Clopidogrel) and the side effects were gum bleeding and bruises. After seeing her relative survive 5 strokes, it was clear that the drug was not working and a personalised treatment regimen was needed.

Funding and Support

With Abdullah's knowledge about genetics and its influence on the way we respond to drugs, him and Flo decided to make genetic information more readily available. The concept of a new service design was born, to enable the use of genetic information within the medical practice, in an accurate, streamlined and affordable way. Our Heart DNA test project was later presented to the West Midlands Academic Health Science Network, and it later received the pre-seed funding that helped set up the minimum viable product of the service and online platform.

Heart DNA Test Launch

Our Heart DNA testing service was launched in mid 2017 and ever since, it has been helping private practices around the UK and abroad to remove patient-physician communication barriers, helping patients minimise their cardiac risks and reach their optimal treatment regimen faster. In the same way, Rightangled's platform has been assisting doctors to have easy access to a complete risk profile of their patients that is objective and evidence-based.

Fitness DNA Test Launch

In early 2019, we fully launched our second specialised genetic testing service that tapped into the fitness and wellbeing markets. The new testing service expanded Rightangled's transatlantic operations with a second branch that later opened in Austin, Texas.

Coronavirus Test Launch

In December 2019, the world has witnessed an unprecedented epidemic emerging from Wuhan City at Hubei province in China. A virus, later known as the SARS-CoV-2 virus, quickly spread across the globe. At Rightangled, like all other businesses, we felt the need to contribute and help people feel more certain and above all to Stay at home, limiting the spread of the virus to the more vulnerable in the society. Hence, we developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA).

Meet the Team...

Joined by our passion for health & innovation

Mr Abdullah Sabyah

Chairman and CEO

A scientist-entrepreneur and a healthcare professional, also the CQC registered manager of Rightangled and a member of the British Heart Foundation Alliance. A member of the Clinical Pharmacogenomics Implementation Consortium in the US. And the inventor of a patent pending-technology for nucleic acid testing on a lateral flow assay.

Floriane Rousse-Marquet

Service Design

A researcher and service design consultant with a background in industrial design. Flo has over 10 years of experience working for leading design consultancies all over the world. Where she has provided extensive research and strategy services for leading pharmaceutical companies, such as GSK and Novo Nordisk. She also worked in global development with international organisations tackling complex systems.

Mr Anas Abuyazid

Corporate Governance

A seasoned banker with Environmental, Social, and Governance (“ESG”) interest. A believer in sustainability. An angel investor across multiple sectors and jurisdictions.

Mr Usman Ahmed

Clinical Governance

A Surgeon and Nationally appointed Clinical Leadership Fellow with the British Orthopaedic Association. Also, an NHS Clinical Entrepreneur in technological platforms that improve clinicians’ collegiality and enhance patient experience.

Dr Sibtain Anwar

Consultant Cardiologist

Dr Sibtain Anwar is a Senior Lecturer and Consultant in the Department of Perioperative Medicine at the Barts Heart Centre - Europe’s largest cardiovascular institution. He also sits on the Pain Medicine Council at the Royal Society of Medicine. He completed clinical training at Imperial College London, while also pursuing his research interests as an Honorary Fellow of the Academic Cardiology Unit at The National Heart and Lung Institute.

Professor Sir John Cunningham

Non-Executive Director

Lead Scientific Advisor, frontline NHS clinician at The Royal Free Hospital and Professor of Nephrology at UCL Medical School. Active researcher with over I00 papers published in peer reviewed journals. Honorary Fellow of Trinity Hall, University of Cambridge.

Dr Ahmed Merghani

Sports Cardiologist

Ahmed graduated from Barts and the London Medical School in 2005, having also accomplished an intercalated BMedSci (hons) degree in Molecular Therapeutics. He attained membership of the Royal College of Physicians in 2008 and went on to achieve a National training number in Cardiology at the West Midlands Deanery. Since then, he has worked as a cardiology registrar in Birmingham and Coventry. In 2012, he pursued an MD degree at St. George’s, University of London.